Marvell Technology (MRVL)
(Delayed Data from NSDQ)
$62.20 USD
+0.07 (0.11%)
Updated Apr 22, 2024 11:56 AM ET
After-Market: $62.90 +0.70 (1.13%) 7:58 PM ET
4-Sell of 5 4
F Value C Growth A Momentum C VGM
Price, Consensus and EPS Surprise
MRVL 62.20 +0.07(0.11%)
Will MRVL be a Portfolio Killer in April?
Zacks Investment Research is releasing its prediction for MRVL based on the 1-3 month trading system that more than doubles the S&P 500.
About Price, Consensus and EPS Surprise
The Price, Consensus and EPS Surprise chart displays the company's stock price along with the consensus estimate and the EPS surprise. Zacks tracks individual sell-side analyst estimates and creates a consensus EPS estimates. The consensus estimate is the average of all the current estimates made available by brokerage analysts. Consensus estimates are more advantageous because they reduce the risk of any single analyst making an incorrect forecast. ZACKS CONSENSUS ESTIMATE = THE AVERAGE OF ALL CURRENT EPS ESTIMATES. EPS Surprise is the difference (expressed as a percentage) between the actual reported quarterly earnings per share (EPS) vs the estimated quarterly EPS. A company that reports $1.10 in actual quarterly EPS vs. $1.00 in estimated quarterly EPS would show a 10% positive EPS surprise. ((Actual EPS - Estimated EPS) / absolute Estimated EPS) *100 = EPS Surprise %.
Zacks News for MRVL
Marvell Technology (MRVL) Sees a More Significant Dip Than Broader Market: Some Facts to Know
Marvell Technology (MRVL) Laps the Stock Market: Here's Why
MRVL: What are Zacks experts saying now?
Zacks Private Portfolio Services
Should You Invest in Marvell (MRVL) Based on Bullish Wall Street Views?
Marvell Technology, Inc. (MRVL) is Attracting Investor Attention: Here is What You Should Know
Marvell Technology (MRVL) Surpasses Market Returns: Some Facts Worth Knowing
Other News for MRVL
3 Tech Stocks to Buy Now: Q2 Edition
All 7 AI Category Portfolios Continued To Decline This Week
Nvidia, Broadcom, Marvell, Monolithic top chip picks into earnings: Oppenheimer
Jim Cramer Is 'Willing To Let This Pharma Stock Catch Fire,' Advises Not To Sell McKesson
3 Best Semiconductor Stocks to Buy in April 2024, According to Analysts